Join
Live feed
·
INSIDERFilingvia Quantisnow
PTC Therapeutics Inc. logo

CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $202,094 worth of shares (2,850 units at $70.91), decreasing direct ownership by 0.72% to 394,070 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
PTCT· PTC Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTCT (PTC Therapeutics Inc.) and more on Quantisnow.